Connection

Syed Hasan to Angiotensin II Type 1 Receptor Blockers

This is a "connection" page, showing publications Syed Hasan has written about Angiotensin II Type 1 Receptor Blockers.
  1. The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19. Obesity (Silver Spring). 2020 11; 28(11):2035.
    View in: PubMed
    Score: 0.574
  2. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
    View in: PubMed
    Score: 0.561
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.